Costas G. Hadjipanayis, M.D., PhD
Principal Investigator of Multicenter Study of 5-ALA
Dr. Hadjipanayis received his medical degree from Jefferson Medical College; completed his residency in neurosurgery at the University of Pittsburgh School of Medicine, simultaneously obtaining his PhD from the Department of Molecular Genetics and Biochemistry.
Designated as a Georgia Cancer Coalition Distinguished Scholar, he was elected 2011 President of the Southeastern Brain Tumor Foundation.
Dr. Hadjipanayis is Professor and Chair, Dept. of Neurosurgery, Mount Sinai Beth Israel; and Director, Neurosurgical Oncology, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai.
Professor Walter Stummer, M.D., Ph.D.
Chairman of Neurosurgery, Munster University Hospital
Dr. Stummer is a world leader in the introduction and implementation of advanced fluorescence-based diagnostic methods in operation microscopy and microneurosurgery.
He is the neurosurgeon who introduced the use of 5-ALA in the resection of high-grade gliomas, and has published extensively on the 5-ALA method, from applied laboratory research to the operation room.
Dr. Georg Widhalm
Assistant Professor, Department of Neurosurgery
Medical University - Vienna, Austria
Dr. Widhalm is a clinical scientist/surgeon who is a leader in fluorescent-guided surgery focusing upon biomarkers and disease detection. His dissertation work was pivotal in demonstrating the use of Gleolan® for low grade Gliomas that are hiding anaplastic malignancies in 48% of the “nonmalignant" patients. This game changing observation affords the use of Gleolan® in all patients in his hospital to assure maximal tumor removal as standard of care. His insight and expertise underlies his translational approach to novel tumor applications.